Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 4-6, 2010, Pages 453-456

  Rybakowska, I ^a   Bakua, S ^a   Klimek, J ^a   Milczarek, R ^a   Smolenski, R T ^a,b   Kaletha, K ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

AMP deaminase; C34T mutation; heart; kinetic properties

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ARTICLE; CASE REPORT; CHILD; ENZYME ACTIVITY; ENZYME KINETICS; GENE ISOLATION; GENE MUTATION; HEART MUSCLE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; PHYSICAL CHEMISTRY; SCHOOL CHILD;

AMP DEAMINASE; CHILD; HETEROZYGOTE; HUMANS; MALE; MUTATION; MYOCARDIUM;

EID: 77953705612     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003741380     Document Type: Article

References (12)

1. Chapman, A.G.; Atkinson, D.E. Stabilization of adenylate energy charge by the adenylate deaminase reaction. J. Biol. Chem. 1973, 248, 8309-8312.
2. Morisaki, T.; Sabina, R.L.; Holmes, E.W. Adenylate deaminase: a multigene family in humans and rats. J. Biol. Chem. 1990, 265, 11482-11486.
3. Purzycka, J. AMP and adenosine aminohydrolases in rat tissues. Acta Biochim. Pol. 1962, 29, 83-93.
4. Makarewicz,W.; Stankiewicz, A. AMP-aminohydrolase of human skeletal muscle: partial purifocation and properties. Biochem. Med. 1974, 10, 180-197.
5. Fishbein,W.N.; Sabina, R.L.; Ogasawara, N.; Holmes, E.W. Immunologic evidence for three isoforms of AMP deaminase (AMPD) in mature skeletal muscle. Biochim. Biophys. Acta 1993, 1163, 97-104.
6. Nowak, G.; Kaletha, K.Molecular forms of human heart muscle AMP deaminase. Biochem. Med. 1991, 263-266.
7. Fishbein, W.N.; Armbrustmacher, V.W.; Griffin, J.L. Myoadenylate deaminase deficiency: a new disease of muscle. Science 1978, 200, 545-548.
8. Verzijl, H.T.; van Engelen, B.G.; Luyten, J.A.; Steenbergen, G.C.; van den Huevel, L.P.; Laak, H.J.; Padberg, G.W.; Wevers, R.A. Genetic characteristics of myoadenylate deaminase deficiency. Ann. Neurol. 1998, 44, 140-143.
9. Fishbein, W.N. Myoadenylate deaminase deficiency:primary and secondary types. Toxicol. Ind. Health 1986, 2, 105-118.
10. Loh, E.; Rebbeck, T.R.; Mahoney, P.D.; DeNofrio, D.; Swain, J.L.; Holmes, E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999, 99, 1422-1425.
11. Chaney, A.L.; Marbach, E.P. Modified reagents for determination of urea and ammonia. Clin. Chem. 1962, 8, 130-132.
12. Kaletha, K.; Nowak, G. Developmental forms of human skeletal-muscle AMP deaminase. The kinetic and regulatory properties of the enzyme. Biochem. J. 1988, 249, 255-261.